- Home
- ADTX vs SGLY Comparison
ADTX vs SGLY Comparison
Compare ADTX & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- SGLY
- Stock Information
- Founded
- ADTX 2017
- SGLY 2001
- Country
- ADTX United States
- SGLY United States
- Employees
- ADTX N/A
- SGLY N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- SGLY
- Sector
- ADTX Health Care
- SGLY
- Exchange
- ADTX Nasdaq
- SGLY Nasdaq
- Market Cap
- ADTX 4.9M
- SGLY 4.5M
- IPO Year
- ADTX 2020
- SGLY 2008
- Fundamental
- Price
- ADTX $1.01
- SGLY $1.29
- Analyst Decision
- ADTX
- SGLY
- Analyst Count
- ADTX 0
- SGLY 0
- Target Price
- ADTX N/A
- SGLY N/A
- AVG Volume (30 Days)
- ADTX 172.4K
- SGLY 61.9K
- Earning Date
- ADTX 11-17-2025
- SGLY 11-13-2025
- Dividend Yield
- ADTX N/A
- SGLY N/A
- EPS Growth
- ADTX N/A
- SGLY N/A
- EPS
- ADTX N/A
- SGLY N/A
- Revenue
- ADTX $12,051.00
- SGLY $2,172,036.00
- Revenue This Year
- ADTX $15,768.94
- SGLY N/A
- Revenue Next Year
- ADTX N/A
- SGLY N/A
- P/E Ratio
- ADTX N/A
- SGLY N/A
- Revenue Growth
- ADTX N/A
- SGLY N/A
- 52 Week Low
- ADTX $0.81
- SGLY $0.54
- 52 Week High
- ADTX $4,698.00
- SGLY $5.49
- Technical
- Relative Strength Index (RSI)
- ADTX 47.27
- SGLY 69.39
- Support Level
- ADTX $0.98
- SGLY $1.11
- Resistance Level
- ADTX $1.11
- SGLY $1.21
- Average True Range (ATR)
- ADTX 0.07
- SGLY 0.09
- MACD
- ADTX 0.01
- SGLY 0.01
- Stochastic Oscillator
- ADTX 54.34
- SGLY 68.63
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.